These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 22565583)

  • 1. Negotiating decisions during informed consent for pediatric Phase I oncology trials.
    Marshall PA; Magtanong RV; Leek AC; Hizlan S; Yamokoski AD; Kodish ED
    J Empir Res Hum Res Ethics; 2012 Apr; 7(2):51-9. PubMed ID: 22565583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Communication about the risks and benefits of phase I pediatric oncology trials.
    Hazen RA; Zyzanski S; Baker JN; Drotar D; Kodish E
    Contemp Clin Trials; 2015 Mar; 41():139-45. PubMed ID: 25638751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Participant Protection in Phase 1 Pediatric Cancer Trials.
    Kimmelman J; Waligora M; Lynch HF
    JAMA Pediatr; 2019 Jan; 173(1):8-9. PubMed ID: 30419141
    [No Abstract]   [Full Text] [Related]  

  • 4. Supporting positive experiences and sustained participation in clinical trials: looking beyond information provision.
    Gillies K; Entwistle VA
    J Med Ethics; 2012 Dec; 38(12):751-6. PubMed ID: 22875981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase I oncology trials: why the therapeutic misconception will not go away.
    Glannon W
    J Med Ethics; 2006 May; 32(5):252-5. PubMed ID: 16648272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unrealistic optimism and the ethics of phase I cancer research.
    Crites J; Kodish E
    J Med Ethics; 2013 Jun; 39(6):403-6. PubMed ID: 23118468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Phase I clinical trials in oncology: a moral dilemma for the investigators].
    Seligmann M
    Presse Med; 2003 Feb; 32(4):147-8. PubMed ID: 12610469
    [No Abstract]   [Full Text] [Related]  

  • 8. Developing ethical strategies to assist oncologists in seeking informed consent to cancer clinical trials.
    Brown RF; Butow PN; Butt DG; Moore AR; Tattersall MH
    Soc Sci Med; 2004 Jan; 58(2):379-90. PubMed ID: 14604623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase 1 oncology trials and informed consent.
    Miller FG; Joffe S
    J Med Ethics; 2013 Dec; 39(12):761-4. PubMed ID: 23161617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Study of cohort-specific consent and patient control in phase I cancer trials.
    Daugherty CK; Ratain MJ; Minami H; Banik DM; Vogelzang NJ; Stadler WM; Siegler M
    J Clin Oncol; 1998 Jul; 16(7):2305-12. PubMed ID: 9667244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patient involvement in informed consent for pediatric phase I cancer research.
    Miller VA; Baker JN; Leek AC; Drotar D; Kodish E
    J Pediatr Hematol Oncol; 2014 Nov; 36(8):635-40. PubMed ID: 24487916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Communicating and understanding the purpose of pediatric phase I cancer trials.
    Cousino MK; Zyzanski SJ; Yamokoski AD; Hazen RA; Baker JN; Noll RB; Rheingold SR; Geyer JR; Alexander SC; Drotar D; Kodish ED
    J Clin Oncol; 2012 Dec; 30(35):4367-72. PubMed ID: 23071225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Qualitative Study into Dependent Relationships and Voluntary Informed Consent for Research in Pediatric Oncology.
    Dekking SA; van der Graaf R; Schouten-van Meeteren AY; Kars MC; van Delden JJ
    Paediatr Drugs; 2016 Apr; 18(2):145-56. PubMed ID: 26755349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Informed consent conversations and documents: A quantitative comparison.
    Koyfman SA; Reddy CA; Hizlan S; Leek AC; Kodish AE;
    Cancer; 2016 Feb; 122(3):464-9. PubMed ID: 26505269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Key stakeholder perceptions about consent to participate in acute illness research: a rapid, systematic review to inform epi/pandemic research preparedness.
    Gobat NH; Gal M; Francis NA; Hood K; Watkins A; Turner J; Moore R; Webb SA; Butler CC; Nichol A
    Trials; 2015 Dec; 16():591. PubMed ID: 26715077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What do people at risk for Alzheimer disease think about surrogate consent for research?
    Schenk DB; Gilman S
    Neurology; 2006 Jun; 66(11):1785-6. PubMed ID: 16769971
    [No Abstract]   [Full Text] [Related]  

  • 17. Ethical issues in pediatric oncology phase I-II trials based on a mother's point of view.
    Oppenheim D; Geoerger B; Hartmann O
    Bull Cancer; 2005 Nov; 92(11):E57-60. PubMed ID: 16316822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Practical communication guidance to improve phase 1 informed consent conversations and decision-making in pediatric oncology.
    Johnson LM; Leek AC; Drotar D; Noll RB; Rheingold SR; Kodish ED; Baker JN
    Cancer; 2015 Jul; 121(14):2439-48. PubMed ID: 25873253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identifying components in consent information needed to support informed decision making about trial participation: An interview study with women managing cancer.
    Abhyankar P; Velikova G; Summers B; Bekker HL
    Soc Sci Med; 2016 Jul; 161():83-91. PubMed ID: 27261532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What do our patients understand about their trial participation? Assessing patients' understanding of their informed consent consultation about randomised clinical trials.
    Behrendt C; Gölz T; Roesler C; Bertz H; Wünsch A
    J Med Ethics; 2011 Feb; 37(2):74-80. PubMed ID: 21098797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.